Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

BACKGROUND: Alzheimer’s disease (AD) is a complex and heterogeneous disease, which requires reliable biomarkers for diagnosis and monitoring disease activity. Preanalytical protocol and technical variability associated with biomarker immunoassays makes comparability of biomarker data across multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Sterling C., Suárez-Calvet, Marc, Suridjan, Ivonne, Minguillón, Carolina, Gispert, Juan Domingo, Jonaitis, Erin, Michna, Agata, Carboni, Margherita, Bittner, Tobias, Rabe, Christina, Kollmorgen, Gwendlyn, Zetterberg, Henrik, Blennow, Kaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883877/
https://www.ncbi.nlm.nih.gov/pubmed/36709293
http://dx.doi.org/10.1186/s13195-023-01168-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883877/
https://www.ncbi.nlm.nih.gov/pubmed/36709293
http://dx.doi.org/10.1186/s13195-023-01168-y

Ejemplares similares